U.S., Feb. 11 -- An application to own the trademark for 'INOGRAFT BIOTHERAPEUTICS' has been filed on May. 13, 2024.
Owner(s):
Inograft Biotherapeutics, Inc.; 3160 Porter Drive, Suite 200, , California
Goods and/or Services:
For: Stem cell-derived drug therapies being biological preparations for the treatment of monogenetic diseases, autoimmune diseases, cancer, and aging-related diseases; stem cell-derived therapeutic pharmaceutical preparations for the treatment of monogenetic diseases, autoimmune diseases, cancer, and aging-related diseases; stem cells for therapeutic treatment of monogenetic diseases, autoimmune diseases, cancer, and aging-related diseases for medical purposes; pharmaceutical preparations as CD47 antagonists, integr...